Global Clinical Nutrition Market Size, Share and Trends Analysis Report, By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Cancer, Neurological Diseases, and Others) and By End-User (Paediatric and Adult), Forecast (2022-2028)

The global clinical nutrition market is anticipated to grow at a significant CAGR of 6.8% during the forecast period (2022-2028). The rising prevalence of metabolic disorders and rising healthcare spending are some of the prominent driving factors of the global clinical nutrition market. The prevalence of metabolic diseases has risen significantly in the last decade. According to the International Diabetes Federation, over 425 million people globally have diabetes, with that figure anticipated to rise to 700 million by 2045. As a result, the rising prevalence of metabolic disorders, as well as the introduction of new products, the market is projected to grow considerably during the forecast period. For instance, Galen had launched PKU EASY Microtabs, a new medicinal meal for people with the rare, inherited metabolic condition phenylketonuria, in February 2020.
The COVID-19 pandemic had generated global health emergency, in which clinical nutrition had emerged as an effective solution to prevent infection and treat infection-related malnutrition. The European Society for Clinical Nutrition and Metabolism, for example, has published nutritional therapy guidelines for COVID-19-infected ICU patients. Thus, COVID-19 pandemic had a positive influence on the global clinical nutrition market.
According to the Global Surgery Foundation, surgery can treat roughly 30% of all ailments globally and requires the direct attention of a surgeon. Clinical nutrition is used extensively during surgeries to reduce the risk of harmful effects on patients and to allow surgeons to work in a controlled environment. As a result of the increased illness burden and surgical volume, the clinical nutrition market is predicted to grow throughout the forecast period. Furthermore, according to the World Ageing Population report, there will be around 727 million people aged 65 and above globally in 2020. By the year 2050, this number is predicted to rise to 1.5 billion. Chronic diseases are more common in the senior population, which often necessitate surgery. In July 2020, Goodmills Innovation launched “Spermidino EVO,” a wheat germ concentrate created specifically for strengthening immunity in the aged population. As a result, market growth is likely to be aided by the expanding older population and the development of clinical nutrition products tailored for their specific needs.
In comparison to the other regions, North America contributes significantly to the growth of clinical nutrition market. In this region, the emergence of COVID-19 has resulted in a shortage of clinical nutritional supplements. According to the American Society for Parenteral and Enteral Nutrition (ASPEN), 23.4% of parenteral products, such as multivitamin infusion (adult and pediatric), amino acids, potassium acetate injection, USP, sodium acetate injection, and sodium chloride, are currently in short supply as of January 2021. Manufacturers have expanded production and are collaborating with merchants and government organizations to help ensure appropriate availability. However, the supply is not up to the demand level in the market.

Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered-
By Application
By End-user

Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

Top Major Key Players:
Abbott, Nestlé Health Science, Baxter, B. Braun Melsungen AG, and Danone, among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Clinical Nutrition Market Report by Segment
By Route of Administration
Malnutrition
Metabolic Disorders
Gastrointestinal Disorders
Cancer
Neurological Diseases
Others

By End-User
Paediatric
Adult